:27175. 17. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ

:27175. 17. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, et al: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:85156.Ahmad et al. Journal of Hematology Oncology 2013, six:77 http://www.jhoonline.org/content/6/1/Page ten of18. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB: Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:31317. 19. Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, et al: Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene 2007, 26:1046055. 20. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, et al: Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in strong cancers. Cancer Res 2007, 67:2187196. 21. Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, et al: Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer.Methoprene Gastroenterology 2006, 131:149. 22. Greer RM, Peyton M, Larsen JE, Girard L, Xie Y, Gazdar AF, et al: SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to many chemotherapy agents in an IAP-dependent but TNF-alpha -independent manner. Cancer Res 2011, 71:7640648. 23. Hajjaji N, Bougnoux P: Selective sensitization of tumors to chemotherapy by marine-derived lipids: a review. Cancer Treat Rev 2013, 39:47388. 24. Xiang Q, Tang H, Yu J, Yin J, Yang X, Lei X: MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2. Pharmazie 2013, 68:27481. 25. Lan Y, Liu X, Zhang R, Wang K, Wang Y, Hua ZC: Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells. Biometals 2013, 26:24154. 26. Ling YH, Li T, Perez-Soler R, Haigentz M Jr: Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib. Cancer Chemother Pharmacol 2009, 64:53948. 27. Orzaez M, Guevara T, Sancho M, Perez-Paya E: Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination remedy. Cell Death Dis 2012, three:e415. 28. Lee JG, Wu R: Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.Ezabenlimab PLoS A single 2012, 7:e48532. 29. Wu ZZ, Sun NK, Chien KY, Chao CC: Silencing with the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation. Biochem Pharmacol 2011, 82:1630640. 30. Cui SY, Huang JY, Chen YT, Song HZ, Feng B, Huang GC, et al: Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.PMID:23773119 Mol Cancer Res 2013, 11:69913. 31. Gottschling S, Schnabel PA, Herth FJ, Herpel E: Are we missing the target Cancer stem cells and drug resistance in non-small cell lung cancer. Cancer Genomics Proteomics 2012, 9:27586. 32. Kubo T, Takigawa N, Osawa M, Harada D, Ninomiya T, Ochi N, et al: Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy. Cancer Sci 2013, 104:784. 33. Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, et al: miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009, 27:1712721. 34. Ko.